波多黎各老年人技术使用与药物获取之间的关系
Joseph Badillo-Salcedo1, Gabriela M Vélez-Jiménez1, Ethan G Rosado-Martínez1
1School of Pharmacy, Medical Sciences Campus, University of Puerto Rico, San Juan, PR 00936, USA.
International journal of environmental research and public health
|October 29, 2025
概括
数字药房服务可能使老年人处于不利地位. 一个经过验证的问卷显示了技术使用和药物获取差距,年轻的老年人认为技术更有帮助,尽管这与药物获取障碍无关.
科学领域:
- 老年学是指老年学的学科.
- 医疗信息学 医疗信息学
- 卫生社会学 卫生社会学
背景情况:
- 随着数字化药房服务的日益普及,老年人 (65岁或以上) 因潜在的技术障碍而面临挑战.
- 了解数字不平等对于在不断变化的医疗保健环境中确保公平的药物获取至关重要.
研究的目的:
- 评估影响老年人获得药物的数字不平等现象.
- 开发和心理验证一个调查问卷测量技术使用和药物获取在这个人口群体.
主要方法:
- 开发和验证西班牙语问卷,其结构有两个因素:技术使用和药物获取.
- 心理测量分析,包括项目歧视,以评估问卷的有效性.
- 统计分析以探索教育,收入,互联网接入,数字技能,年龄和技术感知之间的关系.
主要成果:
- 调查问卷显示了显著的两因素结构,区分技术用户与非用户在药物获取方面 (p < 0.001).
- 高等教育与更高的收入相关,这反过来又与更好的互联网接入和数字技能有关.
- 年轻的参与者 (平均年龄72.9) 认为技术比年长的参与者 (平均年龄76.6;p = 0.001) 更有帮助.
- 感知到的技术实用性与报告中由于技术而导致的药物获取障碍没有显著的相关性 (p = 0.788).
结论:
- 一个新的,经过验证的问卷有效地识别了老年人药房服务中的数字差距.
- 虽然年轻的老年人对技术的看法更为乐观,但这种看法并不能直接防止药物获取问题.
- 该问卷是未来研究和临床应用的宝贵工具,用于解决药物获取的数字差异.
更多相关视频
相关概念视频
01:15Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
227
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
227
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
194
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
194